Diamond et al., 1972 - Google Patents
Photodynamic therapy of malignant tumoursDiamond et al., 1972
View PDF- Document ID
- 15512007875248586786
- Author
- Diamond I
- Mcdonagh A
- Wilson C
- Granelli S
- Nielsen S
- Jaenicke R
- Publication year
- Publication venue
- The Lancet
External Links
Snippet
Porphyrins are powerful photodynamic agents which sensitise cells so that they are damaged when exposed to light. Malignant tumours take up and retain hæmatoporphyrin to a greater extent than does normal tissue. This study is a test of the idea that …
- 201000011510 cancer 0 title abstract description 7
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0009—Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation
- A61K41/0019—Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation by UV, IR, Rx or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Diamond et al. | Photodynamic therapy of malignant tumours | |
| Wang | Effect of room fluorescent light on the deterioration of tissue culture medium | |
| Southam et al. | Homotransplantation of human cell lines | |
| BRPI0414331B1 (en) | "ANTIMICROBIAN COMPOSITION OF PHOTODYNAMIC THERAPY" | |
| Cowled et al. | Comparison of the efficacy of pulsed and continuous‐wave red laser light in induction of photocytotoxicity by haematoporphyrin derivative | |
| BRPI0212172B1 (en) | Photosensitizing agent, process for the preparation of a photosensitizing agent, pharmaceutical composition, uses of a photosensitizing agent or a pharmaceutically acceptable salt thereof, and a photosensitizing agent or a pharmaceutically acceptable salt thereof and a transfer molecule, methods for introducing a transfer molecule into the cytosol of a cell in vitro and for in vitro diagnosing abnormalities or disorders by analyzing a fluid sample or body tissue of a patient, product, and kit for use in photochemotherapy of disturbances or abnormalities of external or internal surfaces of the body | |
| Tochner et al. | Treatment of murine intraperitoneal ovarian ascitic tumor with hematoporphyrin derivative and laser light | |
| Sery | Photodynamic killing of retinoblastoma cells with hematoporphyrin and light | |
| Abramson et al. | The clinical treatment of laryngeal papillomas with hematoporphyrin therapy | |
| WO2021143829A1 (en) | Non-peripheral quaternary ammonium group modified zinc phthalocyanine and method for preparation thereof and application thereof | |
| CN110407864B (en) | Solubilization BODIPY photosensitizer, preparation method and application in preparation of medicine for treating body surface diseases | |
| Liu et al. | Efficacy of multiple low-dose photodynamic TMPYP4 therapy on cervical cancer tumour growth in nude mice | |
| AU2016372575B2 (en) | Method of photodynamic therapy (PDT) for bladder cancer | |
| Even‐Paz et al. | Rifampicin treatment of cutaneous leishmaniasis | |
| Noguchi | Action of certain biological, chemical, and physical agents upon cultures of Leishmania: some observations on plant and insect Herpetomonads | |
| Figge et al. | Effect of hematoporphyrin on X-radiation sensitivity in Paramecium | |
| RU2376985C1 (en) | Means for stem cells activation | |
| CN110151990B (en) | Phthalocyanine-temperature sensitive gel preparation and preparation method thereof | |
| US11654195B2 (en) | Eco-friendly smart photosensitizer and photo-stem cell therapy product comprising same | |
| RU2228775C1 (en) | Photodynamic method for treating the cases of acute and chronic purulent maxillary sinusitis | |
| Hewitt | Rationalizing radiotherapy: some historical aspects of the endeavour | |
| Nakamura et al. | Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines | |
| CN106822169B (en) | Application of cordycepin in preparation of medicine for preventing and/or treating radiation injury | |
| EP0392662B1 (en) | Use of complexes of tetrachloroplatinate with a diazo dye as antitumour agents | |
| Hall | Growth of tumor fragments X-radiated in vitro following pretreatment with cysteine |